Form 4 for HAE HAEMONETICS CORP
Accepted 2023-06-01 00:00:00 ET · period of report 2023-05-30 · accession 0001127602-23-017355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | HAE | Lingamneni Anila | EVP, CTO | S - Sale | $83.33 | -2,304 | 16.8K | -12% | -$192.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-30 | S | D | 2,304 | $83.33 | 16,800 | D | — | — | (F1) This number includes unvested restricted stock units previously reported. |